These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2424813)

  • 1. Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
    Soulier JP; Gozin D; Lefrère JJ
    Haematologia (Budap); 1986; 19(1):3-12. PubMed ID: 2424813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new method of functional assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of hepatocellular carcinoma].
    Soulier JP; Gozin D; Lefrère JJ
    Presse Med; 1985 Nov; 14(40):2049-52. PubMed ID: 3001686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.
    Uehara S; Gotoh K; Handa H; Tomita H; Senshuu M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases.
    Nakao A; Suzuki Y; Isshiki K; Kimura Y; Takeda S; Kishimoto W; Nonami T; Harada A; Takagi H
    Am J Gastroenterol; 1991 Jan; 86(1):62-6. PubMed ID: 1702578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A; Taniguchi K; Inoue S; Harada A; Nonami T; Watanabe K; Takagi H
    Semin Surg Oncol; 1996; 12(3):160-3. PubMed ID: 8727604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
    Soulier JP; Gozin D; Lefrere JJ
    Gastroenterology; 1986 Nov; 91(5):1258-62. PubMed ID: 3019818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
    Bertino G; Ardiri AM; Boemi PM; Ierna D; Interlandi D; Caruso L; Minona E; Trovato MA; Vicari S; Li Destri G; Puleo S
    Panminerva Med; 2008 Sep; 50(3):221-6. PubMed ID: 18927526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
    Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
    Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation assays as diagnostic markers of hepatocellular carcinoma.
    Lefrère JJ; Conard J; Mavier P; Bettan L; Beaugrand M; Gozin D; Lerable J; Dhumeaux D; Samama M
    Thromb Haemost; 1988 Dec; 60(3):468-70. PubMed ID: 2467402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxyprothrombin expression in cancer and/or non-cancer liver tissues: association with survival of patients with resectable hepatocellular carcinoma.
    Tang W; Kokudo N; Sugawara Y; Guo Q; Imamura H; Sano K; Karako H; Qu X; Nakata M; Makuuchi M
    Oncol Rep; 2005 Jan; 13(1):25-30. PubMed ID: 15583797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Watanabe K; Magario N; Yokoo T; Naraki T
    Cancer; 1999 Feb; 85(4):812-8. PubMed ID: 10091758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Ho CH; Lee SD; Chang HT; Wu JC; Tsai YT; Lo KJ
    Scand J Gastroenterol; 1989 Jan; 24(1):47-52. PubMed ID: 2467347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
    Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.